Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
11.03
-0.03 (-0.27%)
At close: Jul 11, 2025, 4:00 PM
11.04
+0.01 (0.09%)
After-hours: Jul 11, 2025, 7:50 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $985.21 million as of July 11, 2025. Its market cap has increased by 124.35% in one year.
Market Cap
985.21M
Enterprise Value
556.77M
1-Year Change
124.35%
Ranking
Category
Stock Price
$11.03
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has increased from $869.34M to $985.21M, an increase of 13.33%. That is a compound annual growth rate of 3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 985.21M | 106.33% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |